Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 2
1994 1
1995 1
1996 2
1997 2
1999 2
2000 1
2001 1
2012 1
2013 1
2014 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Dynamic PET imaging reveals heterogeneity of skeletal muscle insulin resistance.
Ng JM, Bertoldo A, Minhas DS, Helbling NL, Coen PM, Price JC, Cobelli C, Kelley DE, Goodpaster BH. Ng JM, et al. J Clin Endocrinol Metab. 2014 Jan;99(1):E102-6. doi: 10.1210/jc.2013-2095. Epub 2013 Dec 20. J Clin Endocrinol Metab. 2014. PMID: 24170108 Free PMC article.
PET imaging reveals distinctive roles for different regional adipose tissue depots in systemic glucose metabolism in nonobese humans.
Ng JM, Azuma K, Kelley C, Pencek R, Radikova Z, Laymon C, Price J, Goodpaster BH, Kelley DE. Ng JM, et al. Am J Physiol Endocrinol Metab. 2012 Nov 1;303(9):E1134-41. doi: 10.1152/ajpendo.00282.2012. Epub 2012 Sep 11. Am J Physiol Endocrinol Metab. 2012. PMID: 22967498 Free PMC article.
Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography.
Williams KV, Price JC, Kelley DE. Williams KV, et al. Diabetes. 2001 Sep;50(9):2069-79. doi: 10.2337/diabetes.50.9.2069. Diabetes. 2001. PMID: 11522673 Free article.
Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).
Falkner D, Wilson J, Fertig N, Clawson K, Medsger TA Jr, Morel PA. Falkner D, et al. J Rheumatol. 2000 May;27(5):1196-202. J Rheumatol. 2000. PMID: 10813287
Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise.
Colberg SR, Hagberg JM, McCole SD, Zmuda JM, Thompson PD, Kelley DE. Colberg SR, et al. J Appl Physiol (1985). 1996 Nov;81(5):2027-33. doi: 10.1152/jappl.1996.81.5.2027. J Appl Physiol (1985). 1996. PMID: 8941525 Free article. Clinical Trial.
Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
Simoneau JA, Kelley DE. Simoneau JA, et al. J Appl Physiol (1985). 1997 Jul;83(1):166-71. doi: 10.1152/jappl.1997.83.1.166. J Appl Physiol (1985). 1997. PMID: 9216960 Free article. Clinical Trial.
Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
Kelley DE, Simoneau JA. Kelley DE, et al. J Clin Invest. 1994 Dec;94(6):2349-56. doi: 10.1172/JCI117600. J Clin Invest. 1994. PMID: 7989591 Free PMC article.
Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle.
Kelley DE, Williams KV, Price JC, Goodpaster B. Kelley DE, et al. J Nucl Med. 1999 Nov;40(11):1798-804. J Nucl Med. 1999. PMID: 10565773 Free article.
Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women.
Simoneau JA, Colberg SR, Thaete FL, Kelley DE. Simoneau JA, et al. FASEB J. 1995 Feb;9(2):273-8. FASEB J. 1995. PMID: 7781930
Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss.
Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE. Simoneau JA, et al. FASEB J. 1999 Nov;13(14):2051-60. doi: 10.1096/fasebj.13.14.2051. FASEB J. 1999. PMID: 10544188
15 results
Jump to page